Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
INNOVACAP.NSthis companyInnova Captab Limited	₹1,068.90	28.01×	3.62×	2.46×	20.43×	-208.4%	32.6%	10.3%	8.8%	12.9%	8.4%	0.9%	0.32×	1.62×	9.74×	1.87×	0.3%	4	—	2	C
ANUHPHR.NSAnuh Pharma Limited	₹82.78	16.37×	1.91×	0.87×	10.04×	12.6%	17.4%	6.5%	5.3%	11.7%	10.8%	-1.6%	0×	-0.12×	106.58×	2.22×	2.2%	—	—	2	C
IOLCP.NSIOL Chemicals and Pharmaceuticals Limited	₹202.95	15.52×	1.19×	0.92×	8.2×	-108.0%	21.7%	8.1%	5.9%	7.7%	6.9%	1.8%	0.08×	0.26×	12.97×	1.78×	1.4%	4	—	2	C
JUBLPHARMA.NSJubilant Pharmova Limited	₹966.00	32.46×	1.82×	1.56×	12.07×	-242.1%	30.1%	9.9%	4.8%	5.6%	4.0%	-3.4%	0.51×	1.85×	3.87×	1.62×	0.6%	5	—	2	C
MOREPENLAB.NSMorepen Laboratories Limited	₹99.15	21.5×	1.64×	1.13×	12.61×	-82.7%	37.8%	4.9%	5.3%	7.6%	4.7%	-7.1%	0.17×	0.8×	5.43×	2.37×	0.5%	5	5.38	3	B
ORCHPHARMA.NSOrchid Pharma Limited	₹884.00	119.12×	1.9×	3.02×	57.3×	-115.8%	19.5%	0.7%	2.5%	1.6%	0.3%	-11.2%	0.28×	7.27×	0.43×	2.45×	0.0%	4	—	1	C-
Peer median	—	21.5×	1.82×	1.13×	12.07×	-108.0%	21.7%	6.5%	5.3%	7.6%	4.7%	-3.4%	0.17×	0.8×	5.43×	2.22×	0.6%	5	5.38	2	—